Sky Century Investment (SKYI) Net Cash Flow (2012 - 2026)

Sky Century Investment (SKYI) reported Net Cash Flow of $2893.0 for Q1 2026, up 29030.0% quarter-over-quarter from -$10.0 in Q4 2025.

Sky Century Investment (SKYI) Net Cash Flow (2012 - 2026) Analysis & Trends

Sky Century Investment (SKYI) has 6 years of Net Cash Flow data on file, last reported at $2893.0 in Q1 2026.

Net Cash Flow for Q1 2026 came in at $2893.0, changed N/A year-over-year; the trailing twelve-month figure through Feb 2026 was $3360.0 (changed N/A YoY), and the FY2025 annual result was $477.0, changed N/A from the prior year.
Net Cash Flow improved to $2893.0 in Q1 2026 per SKYI's latest filing, from -$10.0 in the prior quarter.
Over five years, Net Cash Flow peaked at $11312.0 in Q2 2025 and troughed at -$10835.0 in Q3 2025.
A 3-year average of -$1447.6 and a median of -$10.0 in 2025 frame the typical range for Net Cash Flow.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Cash Flow (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	202.00 Mn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	-526.00 Mn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-277.40 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-446.50 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-112.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-768.22 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-3.97 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	139.49 Mn
10	Sky Century Investment	-	-	31,666.00	2,893.00

Download Data